Dr. Priyom Bose

Dr. Priyom Bose

Feature Writer

B.Sc. Botany, M.Sc. Plant Biology and Biotechnology, Ph.D. Plant Biology and Biotechnology

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Articles from Priyom

SARS-CoV-2 epidemic management undermined by relationship between symptoms and secondary transmission

SARS-CoV-2 epidemic management undermined by relationship between symptoms and secondary transmission

5 Sep 2021
SARS-CoV-2 fusion peptides play distinct roles according to neutron scattering

SARS-CoV-2 fusion peptides play distinct roles according to neutron scattering

5 Sep 2021
Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

3 Sep 2021
An assessment of post-vaccination immune response to SARS-CoV-2 Delta in elderly and health care workers

An assessment of post-vaccination immune response to SARS-CoV-2 Delta in elderly and health care workers

2 Sep 2021
Can barrier gestures be relaxed without causing a COVID-19 resurgence in France?

Can barrier gestures be relaxed without causing a COVID-19 resurgence in France?

1 Sep 2021
Is regular COVID-19 testing in schools more effective than bubble quarantines?

Is regular COVID-19 testing in schools more effective than bubble quarantines?

1 Sep 2021
Assessing child and caregiver mental health during the COVID-19 pandemic

Assessing child and caregiver mental health during the COVID-19 pandemic

31 Aug 2021
Attenuated virulence and protective immunity in SARS-CoV-2 with a mutation in the S1/S2 cleavage site

Attenuated virulence and protective immunity in SARS-CoV-2 with a mutation in the S1/S2 cleavage site

31 Aug 2021
Development of SARS-CoV-2 antibody escape variants in an immunocompromised individual

Development of SARS-CoV-2 antibody escape variants in an immunocompromised individual

31 Aug 2021
How early interferon curbs SARS-CoV-2 infection

How early interferon curbs SARS-CoV-2 infection

30 Aug 2021

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback